GM101 in Combination with Histone Deacetylase Inhibitor Enhances Anti-Tumor Effects in Desmoplastic Microenvironment
Oncolytic adenoviruses (oAds) have been evaluated in numerous clinical trials due to their promising attributes as cancer therapeutics. However, the therapeutic efficacy of oAds was limited due to variable coxsackie and adenovirus receptor (CAR) expression levels and the dense extracellular matrix (...
Saved in:
Main Authors: | Han-Gyu Chang, Yong-Hyeon Choi, JinWoo Hong, Joung-Woo Choi, A-Rum Yoon, Chae-Ok Yun |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7f74688d253c485e9353a7d625c1d61d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
by: Tandon N, et al.
Published: (2016) -
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
by: Bingyi Zhou, et al.
Published: (2021) -
Identification of the Histone Deacetylases Gene Family in Hemp Reveals Genes Regulating Cannabinoids Synthesis
by: Liu Yang, et al.
Published: (2021) -
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
by: Jacob King, et al.
Published: (2021) -
Molecular cloning and subcellular localization of six HDACs and their roles in response to salt and drought stress in kenaf (Hibiscus cannabinus L.)
by: Wei,Fan, et al.
Published: (2019)